These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3665319)

  • 1. Leveen shunt visualization without function using technetium-99m macroaggregated albumin.
    Algeo JH; Powell M; Couacaud J
    Clin Nucl Med; 1987 Sep; 12(9):741-3. PubMed ID: 3665319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of peritoneovenous shunt patency by intraperitoneal Tc-99m macroaggregated albumin: clinical experience.
    Stewart CA; Sakimura IT; Applebaum DM; Siegel ME
    AJR Am J Roentgenol; 1986 Jul; 147(1):177-80. PubMed ID: 3487212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of peritoneovenous shunt patency with Tc-99m labeled microspheres.
    Madeddu G; D'Ovidio NG; Casu AR; Mura R; Costanza C; Lai N; LeVeen HH
    J Nucl Med; 1983 Apr; 24(4):302-7. PubMed ID: 6220137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of LeVeen-shunt patency using Tc-99m labelled macroaggregated albumin.
    Adil AR; Waqar A
    J Coll Physicians Surg Pak; 2005 Dec; 15(12):821-2. PubMed ID: 16398982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of hydrothorax by intraperitoneal injection of technetium-99m MAA in the evaluation of peritoneovenous shunt patency.
    Stewart CA; Sakimura IT; Siegel ME
    Clin Nucl Med; 1986 Oct; 11(10):696-7. PubMed ID: 3769324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scintiphotographic evaluation of LeVeen peritoneo-venous shunt patency using intraperitoneal Tc-99m-MAA.
    Farrer PA; Friede J; Wexler MJ
    Clin Nucl Med; 1979 Nov; 4(11):451-4. PubMed ID: 509843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LeVeen shunt patency studies: clarification of scinigraphic findings.
    Singh A; Grossman ZD; McAfee JG; Thomas FD
    Clin Nucl Med; 1980 Mar; 5(3):106-8. PubMed ID: 6444562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radionuclide assessment of peritoneo-venous shunt patency.
    Singh A; McAfee JG; Thomas FD; Grossman ZD
    Clin Nucl Med; 1979 Nov; 4(11):447-50. PubMed ID: 509842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of satisfactory response to pleural sclerosis using radiopharmaceuticals: study in a patient with cirrhotic hydrothorax and LeVeen shunt.
    Crawford KL; McDougall IR
    Arch Intern Med; 1982 Jan; 142(1):194-6. PubMed ID: 7053724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in Patterns of
    Ponto JA
    J Nucl Med Technol; 2017 Jun; 45(2):111-113. PubMed ID: 28408704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subintimal dissection of peritoneovenous shunt tubing. Demonstration with radionuclide study.
    Pezzuti RT; Clouse ME; Hill TC; Bothe A; Katz JF
    Clin Nucl Med; 1985 Jun; 10(6):395-7. PubMed ID: 4017389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Observations on the radionuclide assessment of peritoneovenous shunt patency.
    Rosenthall L; Arzoumanian A; Hampson LG; Shennib H
    Clin Nucl Med; 1984 Apr; 9(4):227-35. PubMed ID: 6233057
    [No Abstract]   [Full Text] [Related]  

  • 13. The intraperitoneal use of Technetium Sulphur Colloid.
    Bolitho LE; Andrews JT; Lichtenstein M
    Australas Radiol; 1981 Jul; 25(2):159-61. PubMed ID: 7305786
    [No Abstract]   [Full Text] [Related]  

  • 14. Embolic distribution through patent foramen ovale demonstrated by (99m)Tc-MAA brain SPECT after Valsalva radionuclide venography.
    Hayashida K; Fukuchi K; Inubushi M; Fukushima K; Imakita S; Kimura K
    J Nucl Med; 2001 Jun; 42(6):859-63. PubMed ID: 11390548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A false-negative LeVeen shunt study.
    Williamson MR; Bundrick TJ
    Clin Nucl Med; 1985 Jul; 10(7):486-7. PubMed ID: 4028600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verification of peritoneo-pleural fluid communication and mediastinal lymph nodes by intraperitoneal injection of technetium-99m albumin colloid.
    Shih WJ; Ryo UY; Marsano L
    J Nucl Med; 1989 Apr; 30(4):559-60. PubMed ID: 2738679
    [No Abstract]   [Full Text] [Related]  

  • 17. Peritoneovenous shunt scintigraphy to assess shunt patency in patients with refractory ascites.
    Senthil R; Sundaraiya S; Perumalla R; Rela M
    J Clin Exp Hepatol; 2013 Dec; 3(4):347-50. PubMed ID: 25755522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cut-off value for normal versus abnormal right-to-left shunt percentages using (99m)Tc-macroaggregated albumin.
    Ito K; Kurihara K; Ishibashi A; Morooka M; Mitsumoto T; Minamimoto R; Kubota K
    Nucl Med Commun; 2011 Oct; 32(10):936-40. PubMed ID: 21876404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indicators of Lung Shunt Fraction Determined by Technetium-99 m Macroaggregated Albumin in Patients with Hepatocellular Carcinoma.
    Kallini JR; Gabr A; Hickey R; Kulik L; Desai K; Yang Y; Gates VL; Riaz A; Salem R; Lewandowski RJ
    Cardiovasc Intervent Radiol; 2017 Aug; 40(8):1213-1222. PubMed ID: 28280976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of shunt flow in coronary-pulmonary fistula by lung perfusion scintigraphy with technetium-99m macroaggregated albumin.
    Komatsu S; Sakata Y; Ueda Y; Higuchi Y; Ishikura F; Hirayama A; Mishima M; Kusuoka H; Hasegawa M; Kodama K
    Am J Cardiol; 1998 Nov; 82(9):1158-61, A11. PubMed ID: 9817507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.